Clínica de Marly Past Earnings Performance
Past criteria checks 4/6
Clínica de Marly has been growing earnings at an average annual rate of 17.6%, while the Healthcare industry saw earnings growing at 14.6% annually. Revenues have been growing at an average rate of 11.8% per year. Clínica de Marly's return on equity is 12.1%, and it has net margins of 18.3%.
Key information
17.6%
Earnings growth rate
17.1%
EPS growth rate
Healthcare Industry Growth | 13.4% |
Revenue growth rate | 11.8% |
Return on equity | 12.1% |
Net Margin | 18.3% |
Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Clínica de Marly makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Mar 24 | 371,988 | 68,187 | 37,705 | 0 |
31 Dec 23 | 362,905 | 64,681 | 36,964 | 0 |
30 Sep 23 | 349,935 | 62,144 | 36,440 | 0 |
30 Jun 23 | 341,132 | 60,758 | 36,188 | 0 |
31 Mar 23 | 332,114 | 57,489 | 35,171 | 0 |
31 Dec 22 | 321,343 | 54,581 | 33,870 | 0 |
30 Sep 22 | 314,472 | 52,719 | 31,935 | 0 |
30 Jun 22 | 304,336 | 51,659 | 29,829 | 0 |
31 Mar 22 | 290,864 | 49,100 | 28,853 | 0 |
31 Dec 21 | 278,599 | 48,974 | 28,018 | 0 |
30 Sep 21 | 266,440 | 45,594 | 27,369 | 0 |
30 Jun 21 | 244,249 | 39,566 | 27,803 | 0 |
31 Mar 21 | 211,677 | 27,151 | 26,717 | 0 |
31 Dec 20 | 209,776 | 27,451 | 26,881 | 0 |
30 Sep 20 | 214,890 | 27,021 | 26,564 | 0 |
30 Jun 20 | 227,628 | 29,050 | 25,910 | 0 |
31 Mar 20 | 254,752 | 41,515 | 26,343 | 0 |
31 Dec 19 | 249,445 | 37,536 | 25,229 | 0 |
30 Sep 19 | 238,552 | 41,841 | 24,912 | 0 |
30 Jun 19 | 220,942 | 30,744 | 23,961 | 0 |
31 Mar 19 | 204,317 | 24,690 | 22,686 | 0 |
31 Dec 18 | 191,255 | 22,879 | 20,827 | 0 |
30 Sep 18 | 181,006 | 11,940 | 19,904 | 0 |
30 Jun 18 | 175,202 | 17,852 | 19,188 | 0 |
31 Mar 18 | 170,688 | 21,580 | 18,158 | 0 |
31 Dec 17 | 167,573 | 19,088 | 17,646 | 0 |
30 Sep 17 | 165,464 | 22,251 | 15,985 | 0 |
30 Jun 17 | 167,288 | 22,015 | 14,712 | 0 |
31 Mar 17 | 169,261 | 19,745 | 14,784 | 0 |
31 Dec 16 | 169,036 | 20,355 | 14,757 | 0 |
30 Sep 16 | 164,660 | 21,416 | 14,302 | 0 |
30 Jun 16 | 159,971 | 21,958 | 11,546 | 0 |
31 Mar 16 | 154,685 | 20,224 | 12,402 | 0 |
31 Dec 15 | 150,172 | 20,004 | 12,469 | 0 |
30 Sep 15 | 147,162 | 15,410 | 7,761 | 0 |
30 Jun 15 | 147,998 | 17,561 | 18,035 | 0 |
31 Mar 15 | 143,554 | 18,893 | 17,574 | 0 |
31 Dec 14 | 132,053 | 16,201 | 11,132 | 0 |
30 Sep 14 | 132,291 | 18,342 | 17,146 | 0 |
30 Jun 14 | 132,995 | 17,377 | 17,425 | 0 |
31 Mar 14 | 127,937 | 16,199 | 16,417 | 0 |
31 Dec 13 | 126,287 | 16,630 | 15,488 | 0 |
30 Sep 13 | 129,330 | 15,940 | 16,773 | 0 |
Quality Earnings: MARLY has high quality earnings.
Growing Profit Margin: MARLY's current net profit margins (18.3%) are higher than last year (17.3%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: MARLY's earnings have grown by 17.6% per year over the past 5 years.
Accelerating Growth: MARLY's earnings growth over the past year (18.6%) exceeds its 5-year average (17.6% per year).
Earnings vs Industry: MARLY earnings growth over the past year (18.6%) did not outperform the Healthcare industry 29%.
Return on Equity
High ROE: MARLY's Return on Equity (12.1%) is considered low.